510(k) Report

510(k) · Cleared

Recalled · 2007

Modification to Hipstar Femoral Stem

K063822510(k) SpecialCleared Jan 25, 200730-day reviewClass II21 CFR 888.3358Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Stryker Orthopaedics · LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented

Cleared on Jan 25, 2007 as substantially equivalent to K051223 (Stryker Orthopaedics, 2006) after a 30-day review. Its family tree reaches back 4 generations to 1987. It has been recalled once.

Decided
Jan 25, 2007
Review
30 days
Class
Class II
Product code
LPH
Recalls
1
Predicates
1

Its longest line of descent runs back 4 generations to K871453 (1987). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK871453 Zweymueller-SL Hip Prosthesis StemAllo Pro Corp. · 1987
  2. 3 generations backK962101 Zweymueller SL Femoral Hip StemIntermedics Orthopedics · 1996
  3. 2 generations backK030373 Alloclassic Zweymueller SL/SLL Femoral StemCenterpulse Orthopedics, Inc. · 2003 · Recalled
  4. 1 generation backK051223 Hipstar Femoral StemStryker Orthopaedics · 2006 · Recalled
  5. This deviceK063822 Modification to Hipstar Femoral StemStryker Orthopaedics · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K871453Zweymueller-SL Hip Prosthesis StemAllo Pro Corp.1987—
−3K962101Zweymueller SL Femoral Hip StemIntermedics Orthopedics1996—
−2K030373Alloclassic Zweymueller SL/SLL Femoral StemCenterpulse Orthopedics, Inc.20031
−1K051223Hipstar Femoral StemStryker Orthopaedics20061
0 (this device)K063822Modification to Hipstar Femoral StemStryker Orthopaedics2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
FIG. 1 — Lineage of K063822, 1987–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LPH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LPH device

  1. #1 K233498 Stryker Orthopaedics Hip Systems Labeling Updatescore 24.3 · 20 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K051223Hipstar Femoral Stem
Summary page 2
…ng other techniques * intended for cementless fixation. Substantial Equivalence: The subject Hipstar femoral stem is a modification to the Hipstar stem cleared in K051223. The determination of the substantial equivalence of the Hipstar hip stem is based on its similarities in intended use, design an…
Stryker Orthopaedics20061

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 28, 2007Not classifiedZ-0463-2008Packaging process controlMis-labeled: The warning label "Do not use with heads more than +10mm offset" does not appear on 127 degree stem boxes.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 6.5 years on median.
  • 2 of the 5 ancestors have a recall of any class.

How does its category compare?

All LPH devices

LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LPH

12in 2025

2007: 102008: 102009: 32010: 152011: 162012: 252013: 112014: 202015: 182016: 102017: 122018: 92019: 222020: 72021: 82022: 142023: 102024: 62025: 122026 (partial year): 8
2007high 25 (2012) · low 3 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LPH

153in 2025

2007: 116 days median2008: 86 days median2009: 112 days median2010: 100 days median2011: 110 days median2012: 76 days median2013: 135 days median2014: 129 days median2015: 111 days median2016: 150 days median2017: 121 days median2018: 145 days median2019: 164 days median2020: 164 days median2021: 410 days median2022: 247 days median2023: 111 days median2024: 92 days median2025: 153 days median2026 (partial year): 256 days median
2007high 410 (2021) · low 76 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LPH

4in 2025

2007: 162008: 12009: 22010: 222011: 262012: 302013: 92014: 32015: 12016: 82017: 142018: 22019: 82020: 62021: 42022: 22023: 22024: 12025: 42026 (partial year): 2
2007high 30 (2012) · low 1 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LPH

6,163in 2025

2007: 5092008: 7062009: 1,1562010: 2,0072011: 3,3202012: 3,7852013: 5,0022014: 5,1632015: 5,8302016: 4,9002017: 5,3122018: 5,9542019: 7,1302020: 5,4292021: 5,9782022: 5,2232023: 5,3452024: 5,6262025: 6,163
2007high 7,130 (2019) · low 509 (2007)2025

MAUDE reports naming product code LPH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071011616509
200810861706
2009311221,156
201015100222,007
201116110263,320
20122576303,785
20131113595,002
20142012935,163
20151811115,830
20161015084,900
201712121145,312
2018914525,954
20192216487,130
2020716465,429
2021841045,978
20221424725,223
20231011125,345
202469215,626
20251215346,163
202682562—

What is it indicated for?

noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis;

rheumatoid arthritis (excepting the Osteolock™ HA Acetabular Cup and Peri-Apatite coated prostheses);

correction of functional deformity;

revision procedures where other treatments or devices have failed; and,

treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063822: Modification to Hipstar Femoral Stem.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063822

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026